NIH Funding · FY2024
Total Funding
$4.1M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#1,579
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $4.1M across 4 grants · National rank #1579.
Top grants by award amount
Jeff T Hutchins's NIH grant portfolio, ranked by award amount.
- 1R44AI177199-01A1R44SBIR: IND-enabling development of IN-007, an inhaled muco-trapping immunotherapy for COVID19 and other ACE2-targeted infections$1Maward amount
- 1R44AI181347-01A1R44IND-enabling development for IN-003, an inhaled mAb therapy against human metapneumovirus infection$1Maward amount
- 1R44AI186834-01R44Pharmacokinetics analysis from first-in-human study of IN-002, a potent inhaled muco-trapping antibody therapy for RSV$1Maward amount
- 5SB1AI179368-02SB1GMP manufacturing and IND Filing of IN-002, a potent inhaled muco-trapping antibody therapy for Respiratory Syncytial Virus$996.8Kaward amount
Affiliation
Institutions that have administered grants for Jeff T Hutchins.
Affiliated with Inhalon Biopharma, Inc. (NC).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardInhalon Biopharma, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1579
- 2024Entered Top 25% NationallyRanked #1579
- 2024Entered Top 10% NationallyRanked #1579
Explore further
Find collaborators for Jeff T Hutchins
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Inhalon Biopharma, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →